Clinical Trials List
2023-03-01 - 2028-10-16
Phase III
Not yet recruiting7
Recruiting1
ICD-10D59.5
Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli]
ICD-10D59.6
Hemoglobinuria due to hemolysis from other external causes
ICD-10D59.8
Other acquired hemolytic anemias
ICD-9283.2
Hemoglobinuria due to hemolysis from external causes
-
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
Co-Principal Investigator
- 何景良 Division of Hematology & Oncology
- 黃子權 Division of Hematology & Oncology
- 張平穎 Division of Hematology & Oncology
- 葉人華 Division of Hematology & Oncology
- 戴明燊 Division of Hematology & Oncology
- 陳佳宏 Division of Hematology & Oncology
- 吳宜穎 Division of Hematology & Oncology
- 賴學緯 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Tzu-Ting Chen Division of Hematology & Oncology
- 陳珈妤 Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- 鄭富銘 Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- 王幸婷 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 黃聖娟 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Jeng-Shiun Du 未分科
- Tsung-Jang Yeh Division of Hematology & Oncology
- 高育青 未分科
- Shih-Feng Cho Division of Hematology & Oncology
- Yi-Chang Liu Division of Hematology & Oncology
- Hui-Ching Wang 未分科
- 莊哲明 未分科
- 王閔宏 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- ZHENG-WEI ZHOU
- 滕傑林 Division of Hematology & Oncology
- CHENG-HSIEN LIN Division of Hematology & Oncology
- Cheng-Lun Lai Division of Hematology & Oncology
- PO-WEI LIAO
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 高小雯 Division of Hematology & Oncology
Co-Principal Investigator
- MING YAO 未分科
- Wen-Chien Chou 未分科
- - -
- Chien-Chin Lin 未分科
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
26 participants
-
Global
202 participants
